C-REACTIVE PROTEIN TESTING MARKET Market Analysis, Industry Outlook & Forecast, 2026-2035
The C-reactive Protein Testing Market continues to evolve as healthcare providers increasingly rely on biomarkers for early disease detection, inflammation monitoring, and cardiovascular risk assessment. Rising awareness of preventive healthcare, advancements in diagnostic technologies, and expanding applications of C-reactive protein (CRP) testing across hospitals, diagnostic laboratories, and research institutions are supporting market development. Growing investments in laboratory automation and precision medicine are further strengthening the adoption of CRP testing solutions across developed and emerging healthcare markets.
Market Outlook and Forecast
The C-reactive Protein Testing Market was valued at USD 3.42 Billion in 2025 and is projected to reach USD 5.21 Billion by 2035, expanding at a CAGR of 4.3% during 2026–2035. The increasing burden of infectious diseases, autoimmune disorders, and cardiovascular conditions continues to create sustained demand for CRP testing worldwide. Healthcare systems are placing greater emphasis on early diagnosis and personalized treatment, making CRP testing an essential component of modern clinical practice.
North America remains the leading regional market due to advanced healthcare infrastructure, widespread adoption of high-sensitivity CRP testing, and significant investments in diagnostic innovation. The presence of leading diagnostic manufacturers and supportive reimbursement policies further contribute to regional growth.
Europe maintains a strong market position with growing focus on preventive healthcare, expanding laboratory networks, and increasing government initiatives supporting early disease detection. Rising awareness regarding cardiovascular health also supports market demand.
Asia Pacific is witnessing rapid expansion owing to improving healthcare infrastructure, increasing healthcare expenditure, growing patient awareness, and expanding diagnostic laboratory capabilities. Countries such as China, India, Japan, and South Korea are investing heavily in advanced diagnostic technologies.
Among product segments, the high-sensitivity CRP (hs-CRP) segment accounted for 60.16% of the market in 2025, reflecting its growing importance in cardiovascular risk assessment and preventive healthcare programs. On the basis of assay type, ELISA continues to emerge as the fastest-growing technology due to its high sensitivity, accuracy, and broad clinical applications in research and diagnostic laboratories.
Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/20175
Top Market Trends
Growing Adoption of High-Sensitivity CRP Testing
Healthcare providers are increasingly utilizing high-sensitivity CRP testing to evaluate cardiovascular disease risk before symptoms develop. Preventive healthcare initiatives and personalized treatment planning continue to increase the demand for hs-CRP diagnostics, particularly among patients with chronic inflammatory conditions.
Expansion of Point-of-Care Diagnostic Technologies
Manufacturers are developing compact and rapid CRP testing devices capable of delivering results within minutes. Point-of-care diagnostics improve clinical decision-making in emergency departments, outpatient clinics, and primary healthcare centers by reducing turnaround time while maintaining diagnostic accuracy.
Digitalization and Laboratory Automation
Clinical laboratories are integrating automated analyzers, digital reporting systems, and artificial intelligence-enabled workflow management to improve testing efficiency. Automated CRP testing platforms minimize manual intervention, reduce operational costs, and improve result consistency across high-volume laboratories.
Increasing Focus on Precision Medicine
Precision medicine continues to transform diagnostic practices by incorporating biomarker-based disease monitoring. CRP testing plays an increasingly important role alongside genomic and molecular diagnostics to support personalized treatment strategies for inflammatory diseases, infections, and chronic illnesses.
Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/20175
Recent Company Developments
- Abbott Laboratories expanded its diagnostic portfolio by introducing enhanced laboratory solutions designed to improve biomarker testing efficiency and clinical workflow automation.
- Roche Diagnostics continued strengthening its immunodiagnostic capabilities through advanced analyzer upgrades that support faster and more accurate CRP testing across healthcare laboratories.
- Siemens Healthineers invested in expanding digital laboratory solutions and integrated diagnostic platforms to improve testing efficiency and clinical decision support.
- Thermo Fisher Scientific expanded research collaborations focused on biomarker discovery and laboratory innovation, supporting broader applications of inflammatory marker testing.
- Danaher Corporation, through its diagnostics businesses, enhanced automation capabilities and expanded laboratory workflow solutions for high-throughput clinical testing.
- bioMérieux strengthened its infectious disease diagnostic portfolio with continued investments in biomarker-based testing technologies supporting early clinical intervention.
- Sysmex Corporation introduced advanced hematology and clinical laboratory automation solutions that complement inflammatory biomarker testing across hospital laboratories.
- QuidelOrtho Corporation continued expanding rapid diagnostic testing capabilities through product innovation and broader commercialization strategies supporting point-of-care healthcare delivery.
- Beckman Coulter invested in improving clinical chemistry platforms with enhanced automation features designed to increase laboratory productivity and testing accuracy.
- Randox Laboratories expanded its biomarker testing portfolio by introducing innovative diagnostic assays supporting inflammation monitoring and preventive healthcare applications.
Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/20175
Related Reports
About Fundamental Business Insights:
Fundamental Business Insights is global market research and consulting company which is engaged in providing in depth market reports to its various types of clients like industrial sectors, financial sectors, universities, non-profit, and corporations. Our goal is to offer the correct information to the right stakeholder at the right time, in a format that enables logical and informed decision making. We have a team of consultants who have experience in offering executive level blueprints of markets and solutions. Our services include syndicated market studies, customized research reports, and consultation.
- Contact us:
- Robbin Fernandez
- Head of Business Development
- Fundamental Business Insights and Consulting
- Email: sales@fundamentalbusinessinsights.com
Read This Report in Regional Languages -
